Opendata, web and dolomites

UBI SIGNED

Biological Integral Biogas Upgrading

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "UBI" data sheet

The following table provides information about the project.

Coordinator
TROVANT TECHNOLOGY SL 

Organization address
address: CALLE JOSE MARIA CASTILVIEJO 45
city: VALLADOLID
postcode: 47016
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TROVANT TECHNOLOGY SL ES (VALLADOLID) coordinator 50˙000.00

Map

 Project objective

Biomethane is an upgraded form of biogas which can be directly used as vehicle fuel or for gas grid injection. Biogas upgrading to biomethane is the process where CO2 and other undesired components present in raw biogas, such as H2S, are removed. Cleaning and upgrading biogas makes 30% of the total costs of the final biomethane product or even more in small scale biomethane production. Current physical/chemical technologies are expensive, energy intensive and are not designed for small-scale (<200Nm3/h raw biogas), with operational and investment costs increasing exponentially in low production scenarios. This hinders the widespread production and use of biomethane. Trovant Technology is addressing this limitation with its UBI technology. UBI is a simple, cost effective biogas upgrading technology, based on biological processes, and specifically designed for small scale. It reduces energy requirements and operating costs. In addition, it captures and stores the CO2 removed from the biogas in the form of biomass, which is readily available for new biogas generation. UBI holds the potential to disrupt de-localized biomethane production making it economically feasible in scenarios where it is not considered an option nowadays. Our preliminary market data show that Europe dominates the biomethane market, concentrating 75% of the global business. UBI will compete in the biogas upgrading equipment market, which is expected to reach 1,200 Million US$ by 2024. The development of this technology to market is aligned with Trovant’s strategy for growth and consolidation as a leader in the biomethane sector. As a next step, we will carry out a solid feasibility study covering all the aspects required prior to market launch: detailed analysis of the technical development needed, in-depth commercial feasibility study including a detailed market assessment; and a thorough financial plan covering all the following stages.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "UBI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "UBI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Project Tracworx (2019)

Tracworx is a data analytics tool that allows you to establish bottlenecks in your patient flow, while understanding your efficiencies and ultimately your true capacity.

Read More  

RDNA (2019)

Empowering New Venture Growth - RDNA

Read More  

MEDIVAC (2019)

Machine learning software to design personalized neoantigen vaccines tailored to specific vaccine delivery systems

Read More